STOCK TITAN

Catalent Stock Price, News & Analysis

CTLT NYSE

Company Description

Overview

Catalent Inc (CTLT) is a global integrated solutions provider specializing in pharmaceutical and biologic development services, innovative drug delivery technologies, and comprehensive manufacturing and packaging solutions. With a heritage of over 80 years, Catalent combines a deep expertise in drug development with a robust commitment to operational excellence. The company acts as a catalyst for success for its partners by streamlining the journey from concept to market, ensuring that molecules are advanced efficiently and effectively.

Core Business Areas

Catalent delivers a wide spectrum of services that address key phases of the pharmaceutical lifecycle. These include:

  • Drug and Biologic Development: Expert formulation development, pre-clinical to clinical manufacturing capabilities, and technology-driven solutions that enhance the bioavailability, solubility, and permeability of drugs.
  • Innovative Drug Delivery Technologies: Cutting-edge solutions designed to optimize the ease and route of administration, addressing critical challenges such as patient compliance and effective dosing.
  • Manufacturing and Packaging Solutions: State-of-the-art controlled manufacturing processes that ensure quality and regulatory compliance, alongside advanced packaging techniques tailored to commercial production requirements.

Market Position and Operational Excellence

Catalent occupies a unique position in the competitive landscape of the pharmaceutical industry. Its strength lies in the breadth and depth of its service offerings, which allow it to support a diverse client base ranging from emerging biotech firms to established pharmaceutical companies. By providing end-to-end solutions, Catalent not only accelerates development timelines but also enhances product performance and market feasibility. This multifaceted approach is instrumental in overcoming common industry challenges, particularly in managing complex supply chains and ensuring consistent product quality.

Global Manufacturing and Supply Chain Capabilities

The company is strategically positioned as a global supplier, capable of addressing manufacturing and commercial packaging needs across different geographies. Catalent’s network of manufacturing and supply facilities is designed to meet the stringent regulatory and quality standards of the sector while providing scalable solutions that can adapt to various target markets. This global footprint underpins its ability to support the distribution and commercialization of pharmaceutical products worldwide.

Research & Development and Technological Innovation

Innovation is central to Catalent's operational philosophy. The company invests significantly in research and development, harnessing advanced technologies to improve drug delivery mechanisms. Its proprietary approaches are tailored to overcome the inherent limitations of traditional pharmaceutical formulations. By integrating science and technology, Catalent enhances product performance, which is critical in an era where efficiency and precision are paramount in therapeutic development. This R&D focus not only streamlines the development process but also drives improvements in therapeutic efficacy and patient compliance.

Integrated Solutions Approach

At its core, Catalent leverages a holistic approach by integrating development, manufacturing, and supply chain solutions. This synergistic model allows the company to serve as a seamless partner throughout the drug lifecycle. The comprehensive service spectrum ensures that each phase, from early-stage development to final product packaging, is managed with a focus on quality, speed, and innovation. The integration of services minimizes the risk of delays and inconsistencies, thereby fostering enhanced drug performance and operational efficiency.

Industry-Specific Expertise

Throughout its operations, Catalent demonstrates a commitment to quality and innovation that is evident in every facet of its business model. By adhering to stringent quality control standards and leveraging technological advancements, the company continues to refine its processes and outcomes. Its methodologies are rooted in decades of industry experience, and its strategic focus on reliable and effective service delivery reinforces its standing as an authoritative source in the pharmaceutical services domain.

In summary, Catalent Inc embodies a synthesis of experience and innovation, offering essential services that underpin critical therapeutic advancements. Its approach is defined by the integration of deep industry knowledge, technological precision, and an unwavering commitment to operational excellence, making it a trusted partner in the complex landscape of drug development and manufacturing.

Stock Performance

$—
0.00%
0.00
Last updated:
-1.14 %
Performance 1 year
$11.5B
Market Cap
181.5M
Shares outstanding

SEC Filings

No SEC filings available for Catalent.

Financial Highlights

$1,023,000,000
Revenue (TTM)
-$129,000,000
Net Income (TTM)
-$0.71
Diluted EPS (TTM)
$61,000,000
Operating Cash Flow
-12.61%
Net Profit Margin
-6.55%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Catalent (CTLT)?

The current stock price of Catalent (CTLT) is $63.48 as of February 7, 2025.

What is the market cap of Catalent (CTLT)?

The market cap of Catalent (CTLT) is approximately 11.5B.

What is the revenue (TTM) of Catalent (CTLT) stock?

The trailing twelve months (TTM) revenue of Catalent (CTLT) is $1,023,000,000.

What is the net income of Catalent (CTLT)?

The trailing twelve months (TTM) net income of Catalent (CTLT) is -$129,000,000.

What is the earnings per share (EPS) of Catalent (CTLT)?

The diluted earnings per share (EPS) of Catalent (CTLT) is -$0.71 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Catalent (CTLT)?

The operating cash flow of Catalent (CTLT) is $61,000,000.

What is the profit margin of Catalent (CTLT)?

The net profit margin of Catalent (CTLT) is -12.61%.

What is the operating margin of Catalent (CTLT)?

The operating profit margin of Catalent (CTLT) is -6.55%.

What is the gross margin of Catalent (CTLT)?

The gross profit margin of Catalent (CTLT) is 17.69%.

What is the current ratio of Catalent (CTLT)?

The current ratio of Catalent (CTLT) is 2.51, indicating the company's ability to pay short-term obligations.

What is the gross profit of Catalent (CTLT)?

The gross profit of Catalent (CTLT) is $181,000,000 on a trailing twelve months (TTM) basis.

What is the operating income of Catalent (CTLT)?

The operating income of Catalent (CTLT) is -$67,000,000.

What is the core business of Catalent Inc?

Catalent Inc focuses on providing integrated solutions for drug and biologic development, innovative delivery technologies, and comprehensive manufacturing and packaging services.

How does Catalent accelerate the development process for pharmaceuticals?

Catalent leverages advanced technologies and a holistic service model that spans early formulation to commercialization, reducing development timelines and enhancing product performance.

What makes Catalent's drug delivery technologies innovative?

The company’s drug delivery solutions improve bioavailability, solubility, and ease of administration, addressing crucial challenges such as dosing efficiency and patient compliance.

How is Catalent positioned in the competitive landscape?

Catalent differentiates itself through its integrated solutions, extensive global manufacturing network, and deep expertise in both drug development and commercial packaging.

What services are included in Catalent's manufacturing capabilities?

Catalent offers scalable manufacturing and packaging solutions that adhere to stringent quality and regulatory standards, ensuring reliable production across diverse markets.

How does Catalent support its global clientele?

With a strategically distributed network of manufacturing and supply facilities, Catalent is equipped to serve diverse global markets while maintaining high-quality standards.

What are the key benefits of Catalent's integrated service approach?

This approach minimizes development risks, streamlines processes from formulation to packaging, and fosters operational efficiency, ultimately enhancing the overall therapeutic value.

How does Catalent maintain quality and innovation in its operations?

Catalent invests in continual research and development and adheres to rigorous quality control protocols, ensuring that its solutions remain reliable and at the forefront of pharmaceutical innovation.